Live Breaking News & Updates on Results Fulfill Goal

Groundbreaking New Study in Lancet Rheumatology Shows Potential Strategy for Safer Steroid Use in Lupus
Dr. Eric Morand Publishes Results Funded by LRA s Distinguished Innovator Award
News provided by
Share this article
Share this article
NEW YORK, April 1, 2021 /PRNewswire/ Results of critical work funded by the Lupus Research Alliance Distinguished Innovator Award to Dr. Eric Morand suggests a path toward making lupus treatment with steroids effective at lower doses, lessening harmful side effects. 
In a study just published in
Lancet Rheumatology, Dr. Morand (with first author rheumatology fellow. Dr. Melissa Northcott) reports identifying a group of biological markers that can indicate how much steroid lupus patients have been exposed to, since the amount that is active in the body is more important than the amount taken. The paper further shows that high activity of proteins made by the immune system, called interferons, can block the eff ....

United States , Eric Morand , Williame Paul , Teodora Staeva , Melissa Northcott , Lupus Research Alliance Board Of Directors , Lupus Research Alliance , Lancet Rheumatology , Results Fulfill Goal , Distinguished Innovator Award , Steroid Resistance , Typei Interferon , Innovator Award , Research Alliance Chief Scientific Officer , Native Americans , Lupus Research , Health Care Amp Hospitals , Medical Pharmaceuticals , Polls And Research , Not For Profit , ஒன்றுபட்டது மாநிலங்களில் , எரிக் மோறண்ட் , மெலிசா நார்த்காட் , லூபஸ் ஆராய்ச்சி கூட்டணி பலகை ஆஃப் இயக்குநர்கள் , லூபஸ் ஆராய்ச்சி கூட்டணி , முடிவுகள் நிறைவேற்றுங்கள் இலக்கு ,